» Articles » PMID: 30840927

LINC00702 Suppresses Proliferation and Invasion in Non-small Cell Lung Cancer Through Regulating MiR-510/PTEN Axis

Overview
Specialty Geriatrics
Date 2019 Mar 7
PMID 30840927
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Long non-coding RNAs (lncRNAs) have been consistently reported to be involved in the progression of non-small cell lung cancer (NSCLC). In this study, we aimed to identify aberrantly expressed lncRNAs in NSCLC, in order to explore new therapeutic targets for NSCLC.

Methods: Two pairs of NSCLC and adjacent normal tissues were first analyzed by RNA sequencing. The expressions of LINC00702 in 40 pairs patient samples and in 4 NSCLC cell lines was measured by quantitative real-time PCR. Putative target miRNAs of LINC00702 were predicted by the bioinformatics tools. The effect of LINC00702 on tumor growth was evaluated.

Results: LINC00702 was significantly down-regulated in patients with NSCLC, which was correlated with tumor size and metastasis. In addition, overexpression of LINC00702 markedly suppressed proliferation and metastasis in NSCLC cells via inducing apoptosis and . Moreover, bioinformatics and luciferase reporter assays demonstrated that LINC00702 functioned as a competing endogenous RNA (ceRNA) for miR-510 in NSCLC, and upregulated its target gene PTEN.

Conclusion: Our results indicated that LINC00702 modulated the expression of PTEN gene by acting as a ceRNA for miR-510 in NSCLC. Therefore, LINC00702 may serve as a potential target for the diagnosis and treatment of patients with NSCLC.

Citing Articles

Pancreatic cancer-derived exosomal miR-510 promotes macrophage M2 polarization and facilitates cancer cell aggressive phenotypes.

Wang T, Ye L, Zhou Y, Zhang X, Li R, Zhou Y Hum Cell. 2024; 38(1):17.

PMID: 39528705 DOI: 10.1007/s13577-024-01144-0.


The Role of microRNAs in Hepatocellular Cancer: A Narrative Review Focused on Tumor Microenvironment and Drug Resistance.

Tavakoli Pirzaman A, Alishah A, Babajani B, Ebrahimi P, Sheikhi S, Moosaei F Technol Cancer Res Treat. 2024; 23:15330338241239188.

PMID: 38634139 PMC: 11025440. DOI: 10.1177/15330338241239188.


Dual-Specificity Phosphatases in Regulation of Tumor-Associated Macrophage Activity.

Patysheva M, Prostakishina E, Budnitskaya A, Bragina O, Kzhyshkowska J Int J Mol Sci. 2023; 24(24).

PMID: 38139370 PMC: 10743672. DOI: 10.3390/ijms242417542.


Knockdown of LINC00702 inhibits the growth and induces apoptosis of breast cancer through the Wnt/β-catenin pathway.

Chai D, Yang C, Liu Y, Li H, Lian B, Bai Z Heliyon. 2023; 9(10):e20651.

PMID: 37860544 PMC: 10582296. DOI: 10.1016/j.heliyon.2023.e20651.


Study of MicroRNA Cluster Located on Chromosome X in Serum and Breast Cancer Tissue.

Rasool A, Haghi M, Feizi M Biochem Genet. 2023; 62(2):1115-1135.

PMID: 37544000 DOI: 10.1007/s10528-023-10448-z.


References
1.
Wang K, Chang H . Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011; 43(6):904-14. PMC: 3199020. DOI: 10.1016/j.molcel.2011.08.018. View

2.
Nicholson A, Chansky K, Crowley J, Beyruti R, Kubota K, Turrisi A . The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung.... J Thorac Oncol. 2016; 11(3):300-11. DOI: 10.1016/j.jtho.2015.10.008. View

3.
Wang Q, Jiang S, Song A, Hou S, Wu Q, Qi L . HOXD-AS1 functions as an oncogenic ceRNA to promote NSCLC cell progression by sequestering miR-147a. Onco Targets Ther. 2017; 10:4753-4763. PMC: 5628688. DOI: 10.2147/OTT.S143787. View

4.
Loewen G, Jayawickramarajah J, Zhuo Y, Shan B . Functions of lncRNA HOTAIR in lung cancer. J Hematol Oncol. 2014; 7:90. PMC: 4266198. DOI: 10.1186/s13045-014-0090-4. View

5.
Gutschner T, Hammerle M, Eissmann M, Hsu J, Kim Y, Hung G . The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2012; 73(3):1180-9. PMC: 3589741. DOI: 10.1158/0008-5472.CAN-12-2850. View